Roivant Sciences Ltd. - Common Shares (NQ:ROIV)

23.44 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist

Price and Volume

Volume	73
Open	23.44
Bid (Size)	23.29 (300)
Ask (Size)	23.62 (300)
Prev. Close	23.44
Today's Range	23.44 - 23.44
52wk Range	8.730 - 23.57
Shares Outstanding	692,072,184
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Roivant Signals Major Pipeline Momentum With Accelerated Timelines ↗

December 11, 2025

Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.

Via Benzinga

Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day

December 11, 2025

From Roivant Sciences

Via GlobeNewswire

Performance

YTD	+6.9%	+6.9%
1 Month	+7.0%	+7.0%
3 Month	+42.9%	+42.9%
6 Month	+106.3%	+106.3%
1 Year	+118.2%	+118.2%

More News

Roivant (ROIV) Q2 2026 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 19, 2025

Via Benzinga

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Earnings Preview For Roivant Sciences ↗

November 07, 2025

Via Benzinga

Looking Into Roivant Sciences Ltd's Recent Short Interest ↗

November 11, 2025

Via Benzinga

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

November 10, 2025

From Roivant Sciences

Via GlobeNewswire

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

October 27, 2025

From Roivant Sciences

Via GlobeNewswire

6 Analysts Assess Roivant Sciences: What You Need To Know ↗

September 18, 2025

Via Benzinga

Roivant Stock Rises After Drug Achieves Goals In Late-Stage Study: Retail Sees Further Rally To $17 ↗

September 17, 2025

Via Stocktwits

Why Roivant Sciences Stock Is Soaring Today ↗

September 17, 2025

Via The Motley Fool

Roivant/Priovant's Experimental Drug Shows Promise In Rare Skin Disease Trial ↗

September 17, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

September 17, 2025

Via Chartmill

Lyft, Oruka Therapeutics, Roivant Sciences, Workday And Other Big Stocks Moving Higher On Wednesday ↗

September 17, 2025

Via Benzinga

Roivant Leaps Into A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease ↗

September 17, 2025

Via Investor's Business Daily

Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)

September 17, 2025

From Roivant Sciences

Via GlobeNewswire

Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List

September 11, 2025

From Roivant Sciences

Via GlobeNewswire

Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

September 04, 2025

From Pulmovant, Inc.

Via GlobeNewswire

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients

September 03, 2025

From Roivant Sciences

Via GlobeNewswire

Why Roivant Sciences Stock Bounced Back on Tuesday ↗

August 12, 2025

Via The Motley Fool

Why Roivant Sciences Stock Was Slipping on Monday ↗

August 11, 2025

Via The Motley Fool

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Via MarketMinute

Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update

August 11, 2025

From Roivant Sciences

Via GlobeNewswire

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Frequently Asked Questions

Is Roivant Sciences Ltd. - Common Shares publicly traded?

Yes, Roivant Sciences Ltd. - Common Shares is publicly traded.

What exchange does Roivant Sciences Ltd. - Common Shares trade on?

Roivant Sciences Ltd. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Roivant Sciences Ltd. - Common Shares?

The ticker symbol for Roivant Sciences Ltd. - Common Shares is ROIV on the Nasdaq Stock Market

What is the current price of Roivant Sciences Ltd. - Common Shares?

The current price of Roivant Sciences Ltd. - Common Shares is 23.44

When was Roivant Sciences Ltd. - Common Shares last traded?

The last trade of Roivant Sciences Ltd. - Common Shares was at 01/13/26 04:00 PM ET

What is the market capitalization of Roivant Sciences Ltd. - Common Shares?

The market capitalization of Roivant Sciences Ltd. - Common Shares is 16.22B

How many shares of Roivant Sciences Ltd. - Common Shares are outstanding?

Roivant Sciences Ltd. - Common Shares has 16B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.